首页 > 最新文献

ANZ Journal of Surgery最新文献

英文 中文
Clinical Impact of Sarcopenia and Sarcopenic Obesity in Acute Pancreatitis: A Systematic Review. 急性胰腺炎中肌肉减少和肌肉减少性肥胖的临床影响:一项系统综述。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-05 DOI: 10.1111/ans.70422
Matta Kuzman, Nejo Joseph, Ramy Nafady, Olivia Kent, Tanmay Tarigonda, Sanjay Pandanaboyana

Background: Acute pancreatitis (AP) is a catabolic disease with a risk of prolonged hospital stay. Patients are at risk of sarcopenia. However, the impact of sarcopenia on clinical outcomes post-AP is poorly explored.

Methods: A search of PUBMED, MEDLINE, and EMBASE databases was performed, and studies published between January 1990 and October 2024 were included.

Results: Ten studies with 2841 patients with a median age of 56.3 years were included. The number of patients with mild, moderate, and severe AP were 771, 545, and 399, respectively. Nine studies used skeletal muscle mass/skeletal muscle index/skeletal muscle attenuation, and one used visceral fat/muscle mass ratio as indicators of sarcopenia, measuring muscle mass at L3 vertebra or measuring psoas muscle volume. One longitudinal study reported that 80% of patients with severe AP were sarcopenic at 12 months. There was a strong correlation between sarcopenia and adverse clinical outcomes and mortality. There is no data on the impact of sarcopenia on quality of life (QOL).

Conclusion: This review suggests an association between sarcopenia and the severity of AP in addition to worse postpancreatitis outcomes. Further prospective studies are needed with standardized definitions for sarcopenia with longitudinal follow-up reporting on QOL.

背景:急性胰腺炎(AP)是一种具有延长住院时间风险的分解代谢疾病。患者有肌肉减少症的风险。然而,骨骼肌减少症对ap后临床结果的影响尚不清楚。方法:检索PUBMED、MEDLINE和EMBASE数据库,纳入1990年1月至2024年10月间发表的研究。结果:纳入10项研究,共2841例患者,中位年龄56.3岁。轻度、中度和重度AP患者分别为771例、545例和399例。9项研究使用骨骼肌质量/骨骼肌指数/骨骼肌衰减,1项研究使用内脏脂肪/肌肉质量比作为肌肉减少的指标,测量L3椎肌质量或测量腰肌体积。一项纵向研究报告,80%的严重AP患者在12个月时肌肉减少。肌肉减少症与不良临床结果和死亡率之间存在很强的相关性。没有关于肌肉减少症对生活质量(QOL)影响的数据。结论:本综述提示肌少症与急性胰腺炎的严重程度以及胰腺炎后更差的预后之间存在关联。需要进一步的前瞻性研究,对肌肉减少症进行标准化定义,并对生活质量进行纵向随访报告。
{"title":"Clinical Impact of Sarcopenia and Sarcopenic Obesity in Acute Pancreatitis: A Systematic Review.","authors":"Matta Kuzman, Nejo Joseph, Ramy Nafady, Olivia Kent, Tanmay Tarigonda, Sanjay Pandanaboyana","doi":"10.1111/ans.70422","DOIUrl":"https://doi.org/10.1111/ans.70422","url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis (AP) is a catabolic disease with a risk of prolonged hospital stay. Patients are at risk of sarcopenia. However, the impact of sarcopenia on clinical outcomes post-AP is poorly explored.</p><p><strong>Methods: </strong>A search of PUBMED, MEDLINE, and EMBASE databases was performed, and studies published between January 1990 and October 2024 were included.</p><p><strong>Results: </strong>Ten studies with 2841 patients with a median age of 56.3 years were included. The number of patients with mild, moderate, and severe AP were 771, 545, and 399, respectively. Nine studies used skeletal muscle mass/skeletal muscle index/skeletal muscle attenuation, and one used visceral fat/muscle mass ratio as indicators of sarcopenia, measuring muscle mass at L3 vertebra or measuring psoas muscle volume. One longitudinal study reported that 80% of patients with severe AP were sarcopenic at 12 months. There was a strong correlation between sarcopenia and adverse clinical outcomes and mortality. There is no data on the impact of sarcopenia on quality of life (QOL).</p><p><strong>Conclusion: </strong>This review suggests an association between sarcopenia and the severity of AP in addition to worse postpancreatitis outcomes. Further prospective studies are needed with standardized definitions for sarcopenia with longitudinal follow-up reporting on QOL.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145686956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How I do an Intrathoracic Hand-Sewn Anastomosis During a Minimally Invasive Oesophagectomy. 我如何在微创食管切除术中进行胸内手工缝合吻合。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-04 DOI: 10.1111/ans.70414
Aadil Rahim, Michael Devadas

Minimally invasive oesphagectomy has been found to reduce complications, length of stay and have improved post-operative quality of life compared to open oesophagectomy. Multiple techniques of the oesophagogastric anastomosis have been described in Australia including a three-stage approach with a neck anastomosis and a two-stage approach utilising the trans-orally placed anvil. We describe a two-stage approach with an intra-thoracic hand-sewn anastomosis for a junctional oesophageal cancer.

与开放式食管切除术相比,微创食管切除术减少了并发症,缩短了住院时间,改善了术后生活质量。澳大利亚描述了多种食管胃吻合技术,包括颈部吻合的三阶段入路和利用经口放置砧的两阶段入路。我们描述了一种两阶段的方法,胸内手工缝合吻合术治疗结性食管癌。
{"title":"How I do an Intrathoracic Hand-Sewn Anastomosis During a Minimally Invasive Oesophagectomy.","authors":"Aadil Rahim, Michael Devadas","doi":"10.1111/ans.70414","DOIUrl":"https://doi.org/10.1111/ans.70414","url":null,"abstract":"<p><p>Minimally invasive oesphagectomy has been found to reduce complications, length of stay and have improved post-operative quality of life compared to open oesophagectomy. Multiple techniques of the oesophagogastric anastomosis have been described in Australia including a three-stage approach with a neck anastomosis and a two-stage approach utilising the trans-orally placed anvil. We describe a two-stage approach with an intra-thoracic hand-sewn anastomosis for a junctional oesophageal cancer.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145666883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australia Is Not Surgical Trial Ready. 澳大利亚尚未做好手术试验的准备。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-02 DOI: 10.1111/ans.70411
Rachelle Buchbinder, Richard S Page, Jonathan G Quicke, Nadine E Foster, Manuela L Ferreira, Ian A Harris
{"title":"Australia Is Not Surgical Trial Ready.","authors":"Rachelle Buchbinder, Richard S Page, Jonathan G Quicke, Nadine E Foster, Manuela L Ferreira, Ian A Harris","doi":"10.1111/ans.70411","DOIUrl":"https://doi.org/10.1111/ans.70411","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: The Impact of High Complexity Total Pelvic Exenteration on Surgeon Fatigue: The FaME Study. 高复杂性全盆腔切除术对外科医生疲劳的影响:FaME研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-02 DOI: 10.1111/ans.70420
Pengtao Hu, Hanzhi Sun, Chengyu Lv
{"title":"Re: The Impact of High Complexity Total Pelvic Exenteration on Surgeon Fatigue: The FaME Study.","authors":"Pengtao Hu, Hanzhi Sun, Chengyu Lv","doi":"10.1111/ans.70420","DOIUrl":"https://doi.org/10.1111/ans.70420","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two-Stage Approach. 根治性肾切除术合并腔静脉肿瘤血栓切除术的结果,包括一种新的两阶段入路。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-01 DOI: 10.1111/ans.70404
Daniel Crisafi, Anne Hong, Nathan Papa, Fabian Obrecht, Kirby R Qin, Joel Ding, Marcos Vinicius Perini, Siven Seevanayagam, Peter McCall, Jason Chuen, Sara Qi, Gregory Jack, Joseph Ischia, Damien Bolton, Dixon T S Woon

Background: Renal vein and caval tumour extension occurs in 10%-25% of patients with renal cell carcinoma. This study aims to examine perioperative morbidity and survival outcomes after radical nephrectomy with inferior vena cava tumour thrombectomy at a quaternary institution in Australia.

Methods: This was a retrospective review of nephrectomy with tumour thrombectomy cases between June 2012 and 2022 at a single centre, followed up until September 2024. Overall survival (OS) was visualised by Kaplan-Meier plots and comparisons between survival by presence of metastases, margin status, and thrombus level (I-III vs. IV) were explored with the log-rank test. Recurrence-free survival (RFS) in patients without initial metastases was also examined.

Results: We identified 39 patients, 25 (64%) were male and the median (IQR) age was 64 years (55-69). Metastatic disease was present in 14 patients (36%). Nineteen (49%) had level IV (supradiaphragmatic) tumour thrombus involvement. Six patients (15%) died in hospital, including two intraoperative deaths. A further 14 (36%) experienced Clavien-Dindo grade III or IV complications during their hospital stay. The median OS was 57 months (95% CI: 17-not reached). Excluding those who died in hospital, the median OS was 60 months (95% CI: 33-not reached). There was a significant difference in OS observed by the presence of metastatic disease (p = 0.003), but not with margin status (p = 0.35) or thrombus level (p = 0.22). The median RFS for M0 patients was 60 months (95% CI: 8-not reached).

Conclusion: While associated with high morbidity and mortality, nephrectomy and caval thrombectomy remain an effective treatment option for otherwise fatal advanced RCC.

背景:肾细胞癌患者肾静脉及腔静脉肿瘤扩展发生率为10%-25%。本研究旨在研究澳大利亚一家第四医学机构根治性肾切除术合并下腔静脉肿瘤血栓切除术后围手术期的发病率和生存率。方法:回顾性分析2012年6月至2022年单个中心肾切除术合并肿瘤血栓切除术的病例,随访至2024年9月。Kaplan-Meier图显示了总生存率(OS),并通过log-rank检验比较了转移灶存在、边缘状态和血栓水平(I-III vs. IV)的生存率。没有初始转移的患者的无复发生存期(RFS)也被检查。结果:我们确定了39例患者,25例(64%)为男性,中位(IQR)年龄为64岁(55-69)。14例(36%)患者存在转移性疾病。19例(49%)有IV级(膈上)肿瘤血栓累及。6例患者(15%)在医院死亡,包括2例术中死亡。另有14人(36%)在住院期间经历了Clavien-Dindo III级或IV级并发症。中位生存期为57个月(95% CI: 17-未达到)。排除在医院死亡的患者,中位生存期为60个月(95% CI: 33-未达到)。转移性疾病的存在观察到OS的显著差异(p = 0.003),但与边缘状态(p = 0.35)或血栓水平(p = 0.22)无关。M0患者的中位RFS为60个月(95% CI: 8-未达到)。结论:尽管与高发病率和死亡率相关,肾切除术和腔静脉血栓切除术仍然是致命的晚期肾细胞癌的有效治疗选择。
{"title":"Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two-Stage Approach.","authors":"Daniel Crisafi, Anne Hong, Nathan Papa, Fabian Obrecht, Kirby R Qin, Joel Ding, Marcos Vinicius Perini, Siven Seevanayagam, Peter McCall, Jason Chuen, Sara Qi, Gregory Jack, Joseph Ischia, Damien Bolton, Dixon T S Woon","doi":"10.1111/ans.70404","DOIUrl":"https://doi.org/10.1111/ans.70404","url":null,"abstract":"<p><strong>Background: </strong>Renal vein and caval tumour extension occurs in 10%-25% of patients with renal cell carcinoma. This study aims to examine perioperative morbidity and survival outcomes after radical nephrectomy with inferior vena cava tumour thrombectomy at a quaternary institution in Australia.</p><p><strong>Methods: </strong>This was a retrospective review of nephrectomy with tumour thrombectomy cases between June 2012 and 2022 at a single centre, followed up until September 2024. Overall survival (OS) was visualised by Kaplan-Meier plots and comparisons between survival by presence of metastases, margin status, and thrombus level (I-III vs. IV) were explored with the log-rank test. Recurrence-free survival (RFS) in patients without initial metastases was also examined.</p><p><strong>Results: </strong>We identified 39 patients, 25 (64%) were male and the median (IQR) age was 64 years (55-69). Metastatic disease was present in 14 patients (36%). Nineteen (49%) had level IV (supradiaphragmatic) tumour thrombus involvement. Six patients (15%) died in hospital, including two intraoperative deaths. A further 14 (36%) experienced Clavien-Dindo grade III or IV complications during their hospital stay. The median OS was 57 months (95% CI: 17-not reached). Excluding those who died in hospital, the median OS was 60 months (95% CI: 33-not reached). There was a significant difference in OS observed by the presence of metastatic disease (p = 0.003), but not with margin status (p = 0.35) or thrombus level (p = 0.22). The median RFS for M0 patients was 60 months (95% CI: 8-not reached).</p><p><strong>Conclusion: </strong>While associated with high morbidity and mortality, nephrectomy and caval thrombectomy remain an effective treatment option for otherwise fatal advanced RCC.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Gaps in Publication: Plastic Surgery in Australasia. 出版中的性别差距:大洋洲的整形外科。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-01 DOI: 10.1111/ans.70410
Caroline Lam, Collette Massy-Westropp, Stuart Hamilton

Background: While studies have explored the gender gap in scientific literature, there is a scarcity of information on the impact within surgical publications. We examine the gender gap in Plastic and Reconstructive Surgery papers across two prominent Australasian journals.

Methods: All original clinical science articles published in AJOPS and ANZ Journal of Surgery were reviewed from 2018 to 2024. The gender of the first and last authors, as well as the subspecialty category, type of paper, journal volume, year and issue were entered in a database for further analysis. In addition, we examined whether first author gender was correlated to the gender of the senior faculty with whom they were co-authored.

Results: A total of 344 papers met the inclusion criteria for the study. Male authorship was more prevalent accounting for 65% in comparison to female authorship at 35%. When selecting for editorials only, male first authors accounted for 83% (43) versus female first authors at 17% (10). Excluding editorials, male first authorship reached 62% (183) while females made up the remaining 38% (108). In terms of senior authorship, males accounted for 80% (234) versus 20% (59).

Conclusion: Despite some fluctuation, our findings demonstrate a persistent disequilibrium in gender representation in the chosen journals which likely reflects the current disparity in the profession. Whether the increased recruitment and retention of female trainees and surgeons, is gradually translating to publication output, is not entirely understood. Further research is needed to identify and address the barriers to publication experienced by women in plastic surgery.

背景:虽然有研究探讨了科学文献中的性别差距,但在外科出版物中缺乏关于其影响的信息。我们检查性别差距在整形和重建外科论文在两个著名的澳大利亚期刊。方法:回顾2018 - 2024年发表在《AJOPS》和《ANZ Journal of Surgery》上的所有临床科学原创文章。第一和最后作者的性别,以及亚专业类别、论文类型、期刊卷数、年份和发行期被输入数据库以供进一步分析。此外,我们还检查了第一作者的性别是否与他们共同撰写的高级教师的性别相关。结果:共有344篇论文符合本研究的纳入标准。男性作者占65%,而女性作者占35%。当只选择社论时,男性第一作者占83%(43),而女性第一作者占17%(10)。除去社论,男性第一作者占62%(183篇),女性占38%(108篇)。在资深作者方面,男性占80%(234),男性占20%(59)。结论:尽管有一些波动,但我们的研究结果表明,在所选期刊中,性别代表性持续不平衡,这可能反映了当前该行业的差距。女性受训人员和外科医生的增加招聘和保留是否逐渐转化为出版物产出,目前还不完全清楚。需要进一步的研究来确定和解决女性在整形手术中遇到的发表障碍。
{"title":"Gender Gaps in Publication: Plastic Surgery in Australasia.","authors":"Caroline Lam, Collette Massy-Westropp, Stuart Hamilton","doi":"10.1111/ans.70410","DOIUrl":"https://doi.org/10.1111/ans.70410","url":null,"abstract":"<p><strong>Background: </strong>While studies have explored the gender gap in scientific literature, there is a scarcity of information on the impact within surgical publications. We examine the gender gap in Plastic and Reconstructive Surgery papers across two prominent Australasian journals.</p><p><strong>Methods: </strong>All original clinical science articles published in AJOPS and ANZ Journal of Surgery were reviewed from 2018 to 2024. The gender of the first and last authors, as well as the subspecialty category, type of paper, journal volume, year and issue were entered in a database for further analysis. In addition, we examined whether first author gender was correlated to the gender of the senior faculty with whom they were co-authored.</p><p><strong>Results: </strong>A total of 344 papers met the inclusion criteria for the study. Male authorship was more prevalent accounting for 65% in comparison to female authorship at 35%. When selecting for editorials only, male first authors accounted for 83% (43) versus female first authors at 17% (10). Excluding editorials, male first authorship reached 62% (183) while females made up the remaining 38% (108). In terms of senior authorship, males accounted for 80% (234) versus 20% (59).</p><p><strong>Conclusion: </strong>Despite some fluctuation, our findings demonstrate a persistent disequilibrium in gender representation in the chosen journals which likely reflects the current disparity in the profession. Whether the increased recruitment and retention of female trainees and surgeons, is gradually translating to publication output, is not entirely understood. Further research is needed to identify and address the barriers to publication experienced by women in plastic surgery.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiomic Artificial Intelligence Models Predicting the Response of Colorectal Cancer Liver Metastases to Chemotherapy-A Systematic Review. 放射学人工智能模型预测结直肠癌肝转移对化疗的反应-系统综述。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-12-01 DOI: 10.1111/ans.70412
Lara Wirth, Eloise Cooper, Xiang Quan Chan, Ranjit Singh, Matthew Wei, Evelyn Hutcheon, Rory Kokelaar, Justin M Yeung

Background: Colorectal cancer liver metastasis (CRCLM) profoundly impacts the overall survival rates of affected individuals. Although chemotherapy remains a cornerstone of treatment, the variability in tumour response presents a considerable challenge to effective clinical management. Radiomics-based artificial intelligence (AI) modelling, utilising pre-treatment imaging, has been proposed as a tool to predict treatment response and inform therapeutic decision-making.

Methods: A systematic search using Clarivate (Web of Science) and Ovid (Embase and MEDLINE) from inception to April 8, 2025, was performed in accordance with Preferred Reporting Items for Reviews and Meta-Analysis (PRISMA) guidelines. Studies evaluating the use of AI radiomics models to predict CRCLM response to chemotherapy treatment, alone or in combination with targeted therapies were identified. Full-text review and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Checklist for Diagnostic Test Accuracy Studies.

Results: Thirteen studies met inclusion criteria. All studies described the development and validation of AI models with no implementation studies. The AI models developed demonstrated a varied ability to predict CRCLM response to chemotherapy. Predictive performance was classified as good in six studies and excellent in three. Model development used differing combinations of imaging modalities (CT or MRI), lesion inclusion criteria, dimensionality (2D vs. 3D), and use of clinical features. Most studies did not validate model performance in an external dataset.

Conclusion: Radiomics-based AI models show potential in predicting chemotherapy response in CRCLM. However, limited external validation and methodological variability currently restrict clinical applicability. Standardisation and prospective validation are required for clinical translation.

背景:结直肠癌肝转移(CRCLM)严重影响患者的总体生存率。虽然化疗仍然是治疗的基石,但肿瘤反应的可变性对有效的临床管理提出了相当大的挑战。基于放射组学的人工智能(AI)建模,利用治疗前成像,已被提出作为预测治疗反应和告知治疗决策的工具。方法:使用Clarivate (Web of Science)和Ovid (Embase和MEDLINE)从成立到2025年4月8日进行系统检索,按照优先报告项目进行综述和荟萃分析(PRISMA)指南。研究评估了使用AI放射组学模型预测CRCLM对化疗的反应,无论是单独治疗还是联合靶向治疗。全文审查和数据提取由两名审稿人独立完成。使用诊断测试准确性研究检查表评估偏倚风险。结果:13项研究符合纳入标准。所有研究都描述了人工智能模型的开发和验证,没有实施研究。开发的人工智能模型显示出预测CRCLM对化疗反应的不同能力。预测性能在6项研究中被归类为良好,在3项研究中被归类为优秀。模型开发使用不同的成像方式(CT或MRI)、病变包含标准、维度(2D vs 3D)和临床特征的组合。大多数研究没有在外部数据集中验证模型的性能。结论:基于放射组学的AI模型在预测CRCLM化疗反应方面具有潜力。然而,有限的外部验证和方法可变性目前限制了临床应用。临床翻译需要标准化和前瞻性验证。
{"title":"Radiomic Artificial Intelligence Models Predicting the Response of Colorectal Cancer Liver Metastases to Chemotherapy-A Systematic Review.","authors":"Lara Wirth, Eloise Cooper, Xiang Quan Chan, Ranjit Singh, Matthew Wei, Evelyn Hutcheon, Rory Kokelaar, Justin M Yeung","doi":"10.1111/ans.70412","DOIUrl":"https://doi.org/10.1111/ans.70412","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer liver metastasis (CRCLM) profoundly impacts the overall survival rates of affected individuals. Although chemotherapy remains a cornerstone of treatment, the variability in tumour response presents a considerable challenge to effective clinical management. Radiomics-based artificial intelligence (AI) modelling, utilising pre-treatment imaging, has been proposed as a tool to predict treatment response and inform therapeutic decision-making.</p><p><strong>Methods: </strong>A systematic search using Clarivate (Web of Science) and Ovid (Embase and MEDLINE) from inception to April 8, 2025, was performed in accordance with Preferred Reporting Items for Reviews and Meta-Analysis (PRISMA) guidelines. Studies evaluating the use of AI radiomics models to predict CRCLM response to chemotherapy treatment, alone or in combination with targeted therapies were identified. Full-text review and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Checklist for Diagnostic Test Accuracy Studies.</p><p><strong>Results: </strong>Thirteen studies met inclusion criteria. All studies described the development and validation of AI models with no implementation studies. The AI models developed demonstrated a varied ability to predict CRCLM response to chemotherapy. Predictive performance was classified as good in six studies and excellent in three. Model development used differing combinations of imaging modalities (CT or MRI), lesion inclusion criteria, dimensionality (2D vs. 3D), and use of clinical features. Most studies did not validate model performance in an external dataset.</p><p><strong>Conclusion: </strong>Radiomics-based AI models show potential in predicting chemotherapy response in CRCLM. However, limited external validation and methodological variability currently restrict clinical applicability. Standardisation and prospective validation are required for clinical translation.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TROPIS Procedure in Complex Anal Fistulas: Single-Center Long-Term Results. 复杂肛瘘的TROPIS手术:单中心长期结果。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-11-28 DOI: 10.1111/ans.70397
Hikmet Pehlevan-Özel, Zeynep Nur Yurdakul, Hüseyin Fahri Martlı, Sabiha Nur Özmen, Sadettin Er, Erdinç Çetinkaya, Tezcan Akın, Özgür Akgül

Background: Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter-preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long-term real-world outcomes remain limited. This study aimed to evaluate long-term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature.

Methods: This retrospective single-center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow-up of 680 ± 120 days.

Results: The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90-660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long-term follow-up. No major incontinence was recorded.

Conclusion: TROPIS appears to be a safe, sphincter-preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long-term follow-up.

背景:经肛门开放括约肌间隙(TROPIS)最近被认为是一种保留括约肌的选择,用于治疗复杂的肛瘘。尽管在大型国际系列研究中报道了高成功率,但关于长期实际结果的数据仍然有限。本研究旨在评估TROPIS的长期疗效,重点关注复发和尿失禁,并与现有文献进行比较。方法:该回顾性单中心队列包括28例在2020年至2023年间接受TROPIS手术的患者。统计数据、瘘的Parks分类、手术细节、复发率、愈合时间和尿失禁结果进行了分析。复发定义为瘘在最初完全愈合后再次出现。使用Wexner评分评估尿失禁。患者平均随访680±120 d。结果:患者平均年龄42.6岁。根据Parks的分类,21例(75%)为经括约肌,5例(17.9%)为外括约肌,2例(7.1%)为复杂的经括约肌(马蹄型)。平均愈合时间36天。90天内无复发;此后,9名患者(32.1%)复发(中位225天,范围90-660)。术后早期轻度尿失禁发生率为42.9%,但在长期随访中仅有5例(17.8%)报告持续轻度症状。没有严重的尿失禁记录。结论:对于复杂肛瘘,TROPIS是一种安全的、保留括约肌的技术,可以提供可接受的愈合和保留的失禁。然而,该队列的复发率高于国际报道,强调需要仔细选择患者,外科专业知识和足够的长期随访。
{"title":"TROPIS Procedure in Complex Anal Fistulas: Single-Center Long-Term Results.","authors":"Hikmet Pehlevan-Özel, Zeynep Nur Yurdakul, Hüseyin Fahri Martlı, Sabiha Nur Özmen, Sadettin Er, Erdinç Çetinkaya, Tezcan Akın, Özgür Akgül","doi":"10.1111/ans.70397","DOIUrl":"https://doi.org/10.1111/ans.70397","url":null,"abstract":"<p><strong>Background: </strong>Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter-preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long-term real-world outcomes remain limited. This study aimed to evaluate long-term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature.</p><p><strong>Methods: </strong>This retrospective single-center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow-up of 680 ± 120 days.</p><p><strong>Results: </strong>The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90-660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long-term follow-up. No major incontinence was recorded.</p><p><strong>Conclusion: </strong>TROPIS appears to be a safe, sphincter-preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long-term follow-up.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145628055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes After Pericranial Flap Reconstruction of the Anterior Skull Base After Transcribriform Resection of Sinonasal Tumors: A Retrospective Study. 鼻窦肿瘤经转录状切除术后前颅底颅周皮瓣重建的疗效:回顾性研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-11-28 DOI: 10.1111/ans.70396
Balaram Ramagiri, Zubair Hasan, Stijn Bekkers, Catherine Barnett, James Bowman, Damian Amato, Benedict Panizza

Background: The nasoseptal flap is commonly used in the reconstruction of the anterior skull base following sinonasal tumor resection, but has limitations in its use.

Methods: A retrospective case series at a quaternary referral center involved 13 consecutive anterior skull base resections reconstructed with a pericranial flap. Data collection included patient demographics, type of resection (endoscopic/open/combined), length of stay, follow-up and complications. The primary outcome was the cerebrospinal fluid (CSF) leakage rate and the secondary outcome was the overall complication rate.

Results: The median age was 64 years (range: 32-75 years), and median follow-up was 24.8 months. Four patients (30.8%) had prior radiotherapy, and 10 patients (76.9%) had adjuvant radiotherapy. Eight patients (61.5%) underwent pure endoscopic resection, while the remaining five (38.5%) had a combined endoscopic resection with an open approach required for an orbital exenteration. None of the patients had an open craniotomy. Post-operative CSF leakage was 7.7% (n = 1) and the overall complication rate was 23.1% (n = 3). In addition to the CSF leak, one patient (7.7%) experienced a tension pneumocephalus and another (7.7%) had a delayed presentation of an ascending intracranial infection.

Conclusions: The pericranial flap is a useful extranasal pedicled flap for reconstruction of the anterior skull base when the nasoseptal flap is not available or inadequate. Complications such as CSF leakage, tension pneumocephalus and ascending intracranial infections are uncommon, though they can be adequately managed when present.

背景:鼻中隔皮瓣是鼻窦肿瘤切除术后常用的前颅底重建,但其应用有局限性。方法:回顾性的病例系列在第四转诊中心涉及13个连续前颅底切除重建颅周瓣。数据收集包括患者人口统计、切除类型(内镜/开放/联合)、住院时间、随访和并发症。主要观察指标为脑脊液漏出率,次要观察指标为总并发症发生率。结果:中位年龄64岁(32 ~ 75岁),中位随访时间24.8个月。既往放疗4例(30.8%),辅助放疗10例(76.9%)。8名患者(61.5%)接受了单纯的内镜切除,而其余5名患者(38.5%)接受了联合内镜切除和开放入路眶内剜除术。所有患者均未接受开颅手术。术后脑脊液漏7.7% (n = 1),总并发症率23.1% (n = 3)。除脑脊液泄漏外,1例患者(7.7%)出现张力性脑积水,另1例患者(7.7%)出现颅内上升感染的延迟表现。结论:颅围皮瓣是鼻外带蒂皮瓣重建前颅底的有效方法。并发症,如脑脊液漏,张力性气颅和颅内上升感染是不常见的,虽然他们可以适当地处理当出现。
{"title":"Outcomes After Pericranial Flap Reconstruction of the Anterior Skull Base After Transcribriform Resection of Sinonasal Tumors: A Retrospective Study.","authors":"Balaram Ramagiri, Zubair Hasan, Stijn Bekkers, Catherine Barnett, James Bowman, Damian Amato, Benedict Panizza","doi":"10.1111/ans.70396","DOIUrl":"https://doi.org/10.1111/ans.70396","url":null,"abstract":"<p><strong>Background: </strong>The nasoseptal flap is commonly used in the reconstruction of the anterior skull base following sinonasal tumor resection, but has limitations in its use.</p><p><strong>Methods: </strong>A retrospective case series at a quaternary referral center involved 13 consecutive anterior skull base resections reconstructed with a pericranial flap. Data collection included patient demographics, type of resection (endoscopic/open/combined), length of stay, follow-up and complications. The primary outcome was the cerebrospinal fluid (CSF) leakage rate and the secondary outcome was the overall complication rate.</p><p><strong>Results: </strong>The median age was 64 years (range: 32-75 years), and median follow-up was 24.8 months. Four patients (30.8%) had prior radiotherapy, and 10 patients (76.9%) had adjuvant radiotherapy. Eight patients (61.5%) underwent pure endoscopic resection, while the remaining five (38.5%) had a combined endoscopic resection with an open approach required for an orbital exenteration. None of the patients had an open craniotomy. Post-operative CSF leakage was 7.7% (n = 1) and the overall complication rate was 23.1% (n = 3). In addition to the CSF leak, one patient (7.7%) experienced a tension pneumocephalus and another (7.7%) had a delayed presentation of an ascending intracranial infection.</p><p><strong>Conclusions: </strong>The pericranial flap is a useful extranasal pedicled flap for reconstruction of the anterior skull base when the nasoseptal flap is not available or inadequate. Complications such as CSF leakage, tension pneumocephalus and ascending intracranial infections are uncommon, though they can be adequately managed when present.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145628086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Patient-Orientated Internet Information on Watch and Wait for Rectal Cancer. 以患者为导向的直肠癌观察和等待网络信息的质量。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2025-11-28 DOI: 10.1111/ans.70392
Justin N F Lam, Geoffrey T Ho, Trevor M Yeung, Simon S Ng

Background: Total mesorectal excision (TsE) for rectal cancer is associated with significant morbidity. The 'Watch and Wait' approach, following a complete clinical response (cCR) to total neoadjuvant therapy (TNT), is increasingly considered as an alternative to surgery. The Internet offers extensive resources but the quality of these resources relating to 'Watch and Wait' is unknown. This study evaluates the availability and quality of online resources on 'Watch and Wait' as an option for patients with rectal cancer.

Methods: Using Google, search phrases: 'patient information watch and wait rectal cancer' and 'patient information non-operative management rectal cancer' were employed. The first 50 results of each search were assessed. Relevant sites meeting inclusion criteria were assessed using the DISCERN instrument, which evaluates the quality of published health information on treatment choices.

Results: Of 100 sites reviewed, three were duplicates. Fourteen sites provided dedicated patient-oriented information. Among non-dedicated sites, there were 63 scientific articles, 7 blogs, 6 resources for surgeons, 3 medical news articles, 2 videos, and 2 blocked sites. Of these 14 websites, 5 (35.7%) were updated within the last 2 years; 8 (57.1%) were associated with hospitals and clinics, and 6 (42.9%) with government or non-profit organizations. Most sites detailed the benefits of non-operative management, but 10 (71.4%) omitted uncertainties or risks. Only two (14.3%) were deemed 'high-quality' by DISCERN criteria.

Conclusion: Online patient resources on 'Watch and Wait' for rectal cancer are limited and often of poor quality. High-quality websites should be identified and recommended to patients wishing to seek further information on this topic.

背景:直肠癌全肠系膜切除(TsE)与显著的发病率相关。“观察和等待”方法,在完全临床反应(cCR)后,全面新辅助治疗(TNT),越来越多地被认为是手术的替代方案。互联网提供了广泛的资源,但这些资源的质量与“观察和等待”是未知的。本研究评估了“观察和等待”在线资源作为直肠癌患者的一种选择的可用性和质量。方法:采用谷歌检索词:“患者信息观察等待直肠癌”和“患者信息非手术管理直肠癌”。对每个搜索的前50个结果进行评估。使用DISCERN工具对符合纳入标准的相关地点进行评估,该工具评估有关治疗选择的公开健康信息的质量。结果:100个站点中有3个是重复的。14个站点提供了专门的面向患者的信息。在非专用网站中,有63篇科学文章、7个博客、6个外科医生资源、3篇医学新闻、2个视频和2个被屏蔽的网站。在这14个网站中,有5个(35.7%)是在过去2年内更新的;8个(57.1%)与医院和诊所有关,6个(42.9%)与政府或非营利组织有关。大多数网站详细说明了非手术治疗的好处,但10家(71.4%)省略了不确定性或风险。只有两家(14.3%)被认为是“高质量”的。结论:直肠癌“观察与等待”的在线患者资源有限,且往往质量较差。应该确定高质量的网站,并推荐给希望寻求有关该主题的进一步信息的患者。
{"title":"Quality of Patient-Orientated Internet Information on Watch and Wait for Rectal Cancer.","authors":"Justin N F Lam, Geoffrey T Ho, Trevor M Yeung, Simon S Ng","doi":"10.1111/ans.70392","DOIUrl":"https://doi.org/10.1111/ans.70392","url":null,"abstract":"<p><strong>Background: </strong>Total mesorectal excision (TsE) for rectal cancer is associated with significant morbidity. The 'Watch and Wait' approach, following a complete clinical response (cCR) to total neoadjuvant therapy (TNT), is increasingly considered as an alternative to surgery. The Internet offers extensive resources but the quality of these resources relating to 'Watch and Wait' is unknown. This study evaluates the availability and quality of online resources on 'Watch and Wait' as an option for patients with rectal cancer.</p><p><strong>Methods: </strong>Using Google, search phrases: 'patient information watch and wait rectal cancer' and 'patient information non-operative management rectal cancer' were employed. The first 50 results of each search were assessed. Relevant sites meeting inclusion criteria were assessed using the DISCERN instrument, which evaluates the quality of published health information on treatment choices.</p><p><strong>Results: </strong>Of 100 sites reviewed, three were duplicates. Fourteen sites provided dedicated patient-oriented information. Among non-dedicated sites, there were 63 scientific articles, 7 blogs, 6 resources for surgeons, 3 medical news articles, 2 videos, and 2 blocked sites. Of these 14 websites, 5 (35.7%) were updated within the last 2 years; 8 (57.1%) were associated with hospitals and clinics, and 6 (42.9%) with government or non-profit organizations. Most sites detailed the benefits of non-operative management, but 10 (71.4%) omitted uncertainties or risks. Only two (14.3%) were deemed 'high-quality' by DISCERN criteria.</p><p><strong>Conclusion: </strong>Online patient resources on 'Watch and Wait' for rectal cancer are limited and often of poor quality. High-quality websites should be identified and recommended to patients wishing to seek further information on this topic.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145628006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ANZ Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1